GlassScriptPhysician profile
Julia K Benko
NPI 1376205583
$1,331.55
in general payments reported to CMS, 2019-2025
14 companies · $162 in 2025
The $162 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $516 · 2023: $384 · 2024: $271 · 2025: $162.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $816.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $815.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Galderma Laboratories, L.P. | $516.48 | 2022-2025 | Dysport |
| Allergan, INC. | $241.41 | 2022 | |
| Revance Therapeutics, INC. | $145.68 | 2025 | Daxxify |
| Inspire Medical Systems, INC. | $91.45 | 2023 | Inspire |
| Abbvie INC. | $79.78 | 2023 | |
| Pfizer INC. | $50.80 | 2022-2023 | |
| Biohaven Pharmaceutical Holding Company LTD. | $41.59 | 2022 | |
| Merz North America, INC. | $41.25 | 2024 | |
| Sanofi Pasteur INC. | $24.94 | 2023 | |
| Dexcom, INC. | $24.37 | 2022 | |
| Amgen INC. | $23.97 | 2023 | Otezla, Repatha |
| Boehringer Ingelheim Pharmaceuticals, INC. | $20.91 | 2023 | Synjardy, Jardiance |
| Bayer Healthcare Pharmaceuticals INC. | $15.82 | 2022 | |
| Novo Nordisk INC | $13.10 | 2023 | Wegovy |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Julia Benko listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.